1. Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer
   Tongdong Shi et al, 2023, Translational Oncology CrossRef
2. Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer
   Yu-Hua Xu et al, 2018, International Journal of Oncology CrossRef
3. Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening
   Kayoung Shin et al, 2020, Cancers CrossRef
4. GSK1904529A, a Potent IGF‐IR Inhibitor, Reverses MRP1‐Mediated Multidrug Resistance
   Pranav Gupta et al, 2017, Journal of Cellular Biochemistry CrossRef
5. IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis
   Maria Mytilinaiou et al, 2017, Experimental Cell Research CrossRef
6. Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1
   Kimberly J. Johnson et al, 2016, Cancer Epidemiology CrossRef
7. Healthy and Unhealthy Plant-Based Diets and Glioma in the Chinese Population
   Weichunbai Zhang et al, 2023, Brain Sciences CrossRef
8. Ferroptosis-related gene signatures in neuroblastoma associated with prognosis
   Yiru Chen et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
9. Novel sphingomyelin biomarkers for brain glioma and associated regulation research on the PI3K/Akt signaling pathway
   Xiao‑Hui Zhai et al, 2019, Oncology Letters CrossRef
10. Assessment of GSK1904529A as a promising anti-osteosarcoma agent
    Hao-Dong Fei et al, 2017, Oncotarget CrossRef